Publications by the researcher in collaboration with Nicanor Vega Díaz (16)

2022

  1. Early glomerular filtration rate changes in living kidney donors and recipients: An example of renal plasticity

    Clinical Kidney Journal, Vol. 15, Núm. 5, pp. 885-894

2021

  1. A new inflammatory-microthrombotic syndrome as an explanation for thrombotic complications in patients with COVID-19

    Revista Espanola de Cardiologia

2020

  1. Erratum: Impact of errors of creatinine and cystatin C equations in the selection of living kidney donors (Clinical Kidney Journal (sfz012) DOI: 10.1093/ckj/sfz012)

    Clinical Kidney Journal

  2. Targeting complement in severe coronavirus disease 2019 to address microthrombosis

    Clinical Kidney Journal

2019

  1. Impact of errors of creatinine and cystatin C equations in the selection of living kidney donors

    Clinical Kidney Journal, Vol. 12, Núm. 5, pp. 748-755

2014

  1. Aproximación metodológica al diseño de un sistema de teleasistencia para pacientes en prediálisis y diálisis peritoneal

    Nefrologia, Vol. 34, Núm. 2, pp. 149-157

2011

  1. Diálisis peritoneal actual comparada con hemodiálisis: Análisis de supervivencia a medio plazo en pacientes incidentes en diálisis en la comunidad canaria en los últimos años

    Nefrologia, Vol. 31, Núm. 2, pp. 174-184

1993

  1. Neisseria mucosa peritonitis in CAPD: Another case of the 'nonpathogenic' neisseriae infection [5]

    Peritoneal Dialysis International

  2. Percutaneous embolization of splenic artery pseudoaneurysm as a treatment of hemoperitoneum in a CAPD patient

    Peritoneal Dialysis International, Vol. 13, Núm. 2, pp. 157-159

1992

  1. Could CAPD modulate the hemodynamic changes induced by rHuEPO treatment?

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 8, pp. 435-439

  2. ESTUDIO CONTROLADO DE LA OSTEODISTROFIA RENAL EN DIALISIS PERITONEAL CONTINUA AMBULATORIA (DPCA). ANALISIS CLINICO, BIOQUIMICO, RADIOLOGICO E HISTOMORFOMETRICO

    Nefrologia, Vol. 12, Núm. 4, pp. 330-339

  3. EVALUACION DEL COMPORTAMIENTO PERITONEAL A MEDIO PLAZO DESPUES DEL TRATAMIENTO CON ERITROPOYETINA

    Nefrologia, Vol. 12, Núm. SUPPL. 1, pp. 99-105

  4. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients

    American Journal of Nephrology, Vol. 12, Núm. 4, pp. 208-211

  5. Low turnover bone disease is the more common form of bone disease in CAPD patients.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 8, pp. 376-380

  6. MODIFICACIONES HEMODINAMICAS INDUCIDAS POR EL TRATAMIENTO CON ERITROPOYETINA DURANTE UN ANO

    Nefrologia, Vol. 12, Núm. SUPPL. 1, pp. 94-98

1991

  1. Arterial calcification in diabetic patients undergoing CAPD.

    Contributions to nephrology, Vol. 89, pp. 205-213